BillTrack50 logo
Free Signup Login
Bill

Bill > A4163

NJ A4163

Requires health insurers to provide coverage for biomarker precision medical testing.

summary

Introduced
04/08/2024
In Committee
12/16/2024
Crossed Over
03/24/2025
Passed
03/24/2025
Dead
Signed/Enacted/Adopted
04/23/2025

Introduced Session

2024-2025 Regular Session

Bill Summary

An Act concerning health insurance coverage for biomarker precision medical testing and supplementing various parts of the statutory law.

AI Summary

This bill requires all health insurance providers in New Jersey, including hospital service corporations, medical service corporations, health service corporations, individual and group health insurance policies, health maintenance organizations, and state health benefits programs, to provide coverage for biomarker precision medical testing. The testing must be used for diagnosing, treating, managing, or monitoring a specific disease or condition, and cannot be used for asymptomatic screening. Coverage will be provided when the testing is recognized by FDA-approved tests, drug indications, FDA drug labels, Medicare/Medicaid coverage determinations, or nationally recognized clinical practice guidelines. The bill mandates that these tests be covered with the same terms and conditions as other medical services, including copayments and deductibles, and must be conducted in a manner that minimizes patient disruption. For Medicaid recipients specifically, the bill ensures that biomarker precision medical testing will be provided at no cost. Biomarker precision medical testing is defined broadly to include various types of genetic and molecular analyses, such as single-analyte tests, multiplex panel tests, and whole genome sequencing. The bill will take effect 90 days after enactment and apply to insurance policies and contracts issued or renewed after that date.

Committee Categories

Budget and Finance, Business and Industry

Sponsors (55)

Vin Gopal (D)*,  Shama Haider (D)*,  Gary Schaer (D)*,  Troy Singleton (D)*,  Shavonda Sumter (D)*,  Bob Auth (R),  John Azzariti (R),  Rosaura Bagolie (D),  Al Barlas (R),  Jim Beach (D),  Jon Bramnick (R),  Tony Bucco (R),  Renee Burgess (D),  Clinton Calabrese (D),  Rob Clifton (R),  Nilsa Cruz-Perez (D),  Chris DePhillips (R),  Patrick Diegnan (D),  John DiMaio (R),  Margie Donlon (D),  Mitchelle Drulis (D),  Aura Dunn (R),  Vicky Flynn (R),  Linda Greenstein (D),  Garnet Hall (D),  Dan Hutchison (D),  Michael Inganamort (R),  Gordon Johnson (D),  Robert Karabinchak (D),  Yvonne Lopez (D),  Michele Matsikoudis (R),  Antwan McClellan (R),  Angela Mcknight (D),  Carmen Morales (D),  Nancy Muñoz (R),  Declan O'Scanlon (R),  Ellen Park (D),  Joe Pennacchio (R),  Luanne Peterpaul (D),  Eliana Pintor Marin (D),  Jessica Ramirez (D),  Verlina Reynolds-Jackson (D),  Gabriel Rodriguez (D),  William Sampson (D),  Alexander Schnall (D),  Erik Simonsen (R),  Bob Singer (R),  Bill Spearman (D),  Shanique Speight (D),  Sterley Stanley (D),  Lisa Swain (D),  Chris Tully (D),  Anthony Verrelli (D),  Benjie Wimberly (D),  Andrew Zwicker (D), 

Last Action

Approved P.L.2025, c.49. (on 04/23/2025)
(1 Companion Bills)

bill text

bill summary

Loading...

bill summary

Loading...
Loading...